Efficacy and safety of novel oral anticoagulants in clinical practice: a report from three centers in Sweden.

In a subgroup analysis of the RE-LY [ 11 ], there was a highly significant interaction between treatment and age for major bleeding, such that patient older than 75 had less benefit on major bleeding than younger patients, irrespective of the renal function.

also in 132,142 other papers